Interview, Fireside Chat
Preventing catastrophic lab accidents & bioweapons development | Jaime Yassif (2021)
- The Nuclear Threat Initiative (NTI) plans to launch an independent, nonprofit international organization by the end of next year to govern bioscience research and reduce risks from deliberate attacks and accidental pathogen releases, which are expected to surpass natural diseases as the primary cause of global catastrophic biological risk in the long term.
- This new entity aims to focus primarily on prevention, detection, and response through a layered defense strategy, with initial core activities prioritizing the development of an international common mechanism for DNA synthesis screening, as NTI estimates fewer than 5% of countries currently effectively oversee dual-use research.
- NTI intends to secure government buy-in for biosecurity norms and establish a "biofunders compact" to incentivize financial institutions, while also leveraging the fact that companies representing approximately 80% of the global DNA synthesis market already employ screening protocols.
- A proposed Joint Assessment Mechanism is being developed to live within the UN system under the authority of the Secretary-General, addressing the current lack of robust tools to investigate biological events of uncertain origin (natural, accidental, or deliberate) through a roster of certified experts determined during peacetime.
- Future efforts will emphasize strengthening deterrence via improved international attribution and accountability tools, increasing transparency to prevent arms races, and fostering collaboration between law enforcement and the scientific community, with Interpol playing a key role in detecting terrorist plots.
- Significant risks include large bureaucracies pursuing irrational activities due to institutional drivers, the potential for weak leadership or loss of focus in new organizations, and the challenge of managing the risks associated with instant self-publication platforms like bioRxiv.
- NTI aims to leverage the political window of opportunity created by the COVID-19 pandemic, viewing the uncertainty of its origin as a catalyst for dramatic steps to reduce laboratory accident risks and improve international biosecurity architecture.
- Strategic priorities include expanding WHO capabilities for pathogen origin investigation, developing medical countermeasures using platform technologies like mRNA, and fostering global norms that require consensus among parties to the Biological Weapons Convention, building on lessons from the seven-to-eight-year verification negotiations of the 1990s.
- The outlook anticipates that the US, UK, and other governments remain open to cooperation, while NTI seeks to recruit expertise from outside the US where the marginal impact is viewed as higher, and to encourage individuals to spend time in government to understand systemic constraints and levers of power.
- NTI expects that institutional changes are more sustainable than technology solutions alone, requiring engagement with stakeholders such as publishers and funders to ensure adherence to global norms and prevent the misuse of emerging technologies like benchtop DNA synthesis.